Ehlerding EB - Search Results

1

ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer.

Ehlerding EB, England CG, Majewski RL, Valdovinos HF, Jiang D, Liu G, McNeel DG, Nickles RJ, Cai W. Ehlerding EB, et al. Mol Pharm. 2017 May 1;14(5):1782-1789. doi: 10.1021/acs.molpharmaceut.7b00056. Epub 2017 Apr 12. Mol Pharm. 2017. PMID: 28388076 Free PMC article.

2

Molecular Imaging of Immunotherapy Targets in Cancer.

Ehlerding EB, England CG, McNeel DG, Cai W. Ehlerding EB, et al. J Nucl Med. 2016 Oct;57(10):1487-1492. doi: 10.2967/jnumed.116.177493. Epub 2016 Jul 28. J Nucl Med. 2016. PMID: 27469363 Free PMC article. Review.

3

CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.

Hernandez R, Sun H, England CG, Valdovinos HF, Ehlerding EB, Barnhart TE, Yang Y, Cai W. Hernandez R, et al. Among authors: ehlerding eb. Theranostics. 2016 Aug 8;6(11):1918-33. doi: 10.7150/thno.15568. eCollection 2016. Theranostics. 2016. PMID: 27570560 Free PMC article.

4

Radiolabeled pertuzumab for imaging of human epidermal growth factor receptor 2 expression in ovarian cancer.

Jiang D, Im HJ, Sun H, Valdovinos HF, England CG, Ehlerding EB, Nickles RJ, Lee DS, Cho SY, Huang P, Cai W. Jiang D, et al. Among authors: ehlerding eb. Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1296-1305. doi: 10.1007/s00259-017-3663-y. Epub 2017 Mar 6. Eur J Nucl Med Mol Imaging. 2017. PMID: 28265738 Free PMC article.

5

CD38 as a PET Imaging Target in Lung Cancer.

Ehlerding EB, England CG, Jiang D, Graves SA, Kang L, Lacognata S, Barnhart TE, Cai W. Ehlerding EB, et al. Mol Pharm. 2017 Jul 3;14(7):2400-2406. doi: 10.1021/acs.molpharmaceut.7b00298. Epub 2017 Jun 8. Mol Pharm. 2017. PMID: 28573863 Free PMC article.

6

⁸⁹Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer.

England CG, Jiang D, Ehlerding EB, Rekoske BT, Ellison PA, Hernandez R, Barnhart TE, McNeel DG, Huang P, Cai W. England CG, et al. Among authors: ehlerding eb. Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):110-120. doi: 10.1007/s00259-017-3803-4. Epub 2017 Aug 19. Eur J Nucl Med Mol Imaging. 2018. PMID: 28821924 Free PMC article.

7

ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.

England CG, Jiang D, Hernandez R, Sun H, Valdovinos HF, Ehlerding EB, Engle JW, Yang Y, Huang P, Cai W. England CG, et al. Among authors: ehlerding eb. Mol Pharm. 2017 Oct 2;14(10):3239-3247. doi: 10.1021/acs.molpharmaceut.7b00216. Epub 2017 Sep 6. Mol Pharm. 2017. PMID: 28825843 Free PMC article.

8

Noninvasive Trafficking of Brentuximab Vedotin and PET Imaging of CD30 in Lung Cancer Murine Models.

Kang L, Jiang D, Ehlerding EB, Barnhart TE, Ni D, Engle JW, Wang R, Huang P, Xu X, Cai W. Kang L, et al. Among authors: ehlerding eb. Mol Pharm. 2018 Apr 2;15(4):1627-1634. doi: 10.1021/acs.molpharmaceut.7b01168. Epub 2018 Mar 20. Mol Pharm. 2018. PMID: 29537283 Free PMC article.

9

Noninvasive PET Imaging of T cells.

Wei W, Jiang D, Ehlerding EB, Luo Q, Cai W. Wei W, et al. Among authors: ehlerding eb. Trends Cancer. 2018 May;4(5):359-373. doi: 10.1016/j.trecan.2018.03.009. Epub 2018 Apr 17. Trends Cancer. 2018. PMID: 29709260 Free PMC article. Review.

10

^86/90Y-Based Theranostics Targeting Angiogenesis in a Murine Breast Cancer Model.

Ehlerding EB, Ferreira CA, Aluicio-Sarduy E, Jiang D, Lee HJ, Theuer CP, Engle JW, Cai W. Ehlerding EB, et al. Mol Pharm. 2018 Jul 2;15(7):2606-2613. doi: 10.1021/acs.molpharmaceut.8b00133. Epub 2018 May 30. Mol Pharm. 2018. PMID: 29787283 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters